Tamoxifen and raloxifene produce conditioned taste avoidance in female rats: A microstructural analysis of licking patterns

Life Sciences

Volumn 84, Issue 9-10, 2009, Pages 282-289

  Fudge, Melissa A ^a   Kavaliers, Martin ^a   Baird, John Paul ^b   Ossenkopp, Klaus Peter ^a  

^a UNIVERSITY OF WESTERN ONTARIO   (Canada)

^b AMHERST COLLEGE   (United States)

Author keywords

Body weight; Estrogen receptor; Ingestion; Lickometer; Selective estrogen receptor modulators; Sucrose

Indexed keywords

ESTRADIOL; RALOXIFENE; SUCROSE; TAMOXIFEN;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANXIETY; ARTICLE; BODY WEIGHT; CONTROLLED STUDY; FEMALE; FLUID INTAKE; FOOD INTAKE; LOCOMOTION; NONHUMAN; OPEN FIELD BEHAVIOR; OVARIECTOMY; RAT; TASTE ACUITY; TASTE DISORDER;

ANIMALS; BEHAVIOR, ANIMAL; BODY WEIGHT; CONDITIONING, OPERANT; DRINKING; FEMALE; HUMANS; OVARIECTOMY; RALOXIFENE; RATS; RATS, LONG-EVANS; SELECTIVE ESTROGEN RECEPTOR MODULATORS; TAMOXIFEN; TASTE;

RATTUS;

EID: 59849085757     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lfs.2008.12.012     Document Type: Article

References (66)

1. Ainslie D.A., Morris M.J., Wittert G., Turnbull H., Proietto J., and Thorburn A.W. Estrogen deficiency causes central leptin insensitivity and increased hypothalamic neuropeptide Y. International Journal of Obesity and Related Metabolic Disorders 25 (2001) 1680-1688
2. Asarian L., and Geary N. Modulation of appetite by gonadal steroid hormones. Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences 361 (2006) 1251-1263
3. Baird J.-P., Grill H.J., and Kaplan J.M. Effect of hepatic glucose infusion on glucose intake and licking microstructure in deprived and nondeprived rats. American Journal of Physiology. Regulatory, Integrative and Comparative Physiology 277 (1999) R1136-R1143
4. Becker J.B., Snyder P.J., Miller M.M., Westgate S.A., and Jenuwine M.J. The influence of estrous cycle and intrastriatal estradiol on sensorimotor performance in the female rat. Pharmacology, Biochemistry and Behavior 27 (1987) 53-59
5. Cakmak A., Posaci C., Dogan E., Caliskan S., Guclu S., and Altunyurt S. Raloxifene increases serum leptin levels I postmenaupausal women: a prospective study. American Journal of Obstetrics Gynecology 193 (2005) 347-351
6. Camoriano J.K., Loprinzi C.L., Ingle J.N., Therneau T.M., Krook J.E., and Veeder M.H. Weight change in women treated with adjuvant therapy or observed following mastectomy for node-positive breast cancer. Journal of Clinical Oncology 8 (1990) 1327-1334
7. Clarke S.N.D.A., and Ossenkopp K.-P. Hormone replacement modifies cholecystokinin-induced changes in sucrose palatability in ovariectomized rats. Peptides 19 (1998) 977-985
8. Clegg D.J., Brown L.M., Woods S.C., and Benoit S.C. Gonadal hormones determine sensitivity to central leptin and insulin. Diabetes 55 (2006) 978-987
9. Davis J.D., and Smith G.P. Analysis of the microstructure of the rhythmic tongue movements of rats ingesting maltose and sucrose solutions. Behavioral Neuroscience 106 (1992) 217-228
10. De Beun R., Jansen E., Smeets M.A.M., Niesing J., Slangen J.L., and van de Poll N.E. Estradiol-induced conditioned taste aversion and place aversion in rats: sex- and dose-dependent effects. Physiology & Behavior 50 (1991) 995-1000
11. Demark-Wahnefried W., Peterson B.L., Winer E.P., Marks L., Aziz N., Marcom P.K., Blackwell K., and Rimer B.K. Changes in weight, body composition, and factors influencing energy balance among premenopausal breast cancer patients receiving adjuvant chemotherapy. Journal of Clinical Oncology 19 (2001) 2381-2389
12. Dywer D.M., Boakes R.A., and Hayward A.J. Reduced palatability in lithium- and activity-based, but not in amphetamine-based, taste aversion learning. Behavioral Neuroscience 122 (2008) 1051-1060
13. Eckel L.A., Houpt T.A., and Geary N. Estradiol treatment increases CCK-induced c-Fos expression in the brains of ovariectomized rats. American Journal of Physiology. Regulatory, Integrative and Comparative Physiology 283 (2002) R1378-R1385
14. Eliassen A.H., Colditz G.A., Rosner B., Willett W.C., and Hankinson S.E. Adult weight change and risk of postmenopausal breast cancer. JAMA: The Journal of the American Medical Association 296 (2006) 193-201
15. Enger S.M., Greif J.M., Polikoff J., and Press M. Body weight correlates with mortality in early-stage breast cancer. Archives of Surgery 139 (2004) 954-960
16. Flanagan-Cato L.M., Grigson P.S., and King J.L. Estrogen-induced suppression of intake is not mediated by taste aversion in female rats. Physiology & Behavior 72 (2001) 549-558
17. Fregly M.J., Rowland N.E., Suners C., and Gordon D.B. Reduced dipsogenic responsiveness to introcerebroventricularly administered angiotensin II in estrogen-treated rats. Brain Research 338 (1985) 115-121
18. Galea L.A.M., Wide J.K., Paine T.A., Holmes M.M., Ormerod B.K., and Floresco S.B. High levels of estradiol disrupt conditioned place preference learning, stimulus response learning and reference memory but have limited effects on working memory. Behavioural Brain Research 126 (2001) 115-126
19. Ganesan R. The aversive and hypophagic effects of estradiol. Physiology & Behavior 55 (1994) 279-285
20. Ganesan R., and Simpkins J.W. The role of conditioned taste aversion in the suppression of food intake by estradiol. Physiology & Behavior 48 (1990) 647-652
21. Ganesan R., and Simpkins J.W. Conditioned taste aversion induced by estradiol pellets. Physiology & Behavior 50 (1991) 849-852
22. Geary N., Asarian L., Korach K.S., Pfaff D.W., and Ogawa S. Deficits in E2-dependent control of feeding, weight gain, and cholecystokinin satiation in ER-α null mice. Endocrinology 142 (2001) 4751-4757
23. Goodwin P.J., and Boyd N.F. Body size and breast cancer prognosis: a critical review of the evidence. Breast Cancer Research and Treatment 16 (1990) 205-214
24. Gray J.M., Schrock S., and Bishop M. Estrogens and antiestrogens: actions and interactions with fluphenazine on food intake and body weight in rats. American Journal of Physiology. Regulatory, Integrative and Comparative Physiology 264 (1993) R1214-R1218
25. Grese T.A., Sluka J.P., Bryant H.U., Cullinan G.J., Glasebrook A.L., Jones C.D., Matsumoto K., Palkowitz A.D., Sato M., Termine J.D., Winter M.A., Yang N.N., and Dodge J.A. Molecular determinants of tissue selectivity in estrogen receptor modulators. Proceedings of the National Academy of Sciences of the United States of America 94 (1997) 14105-14110
26. Hall J.M., Couse J.F., and Korach K.S. The multifaceted mechanisms of estradiol and estrogen receptor signaling. Journal of Biological Chemistry 276 (2001) 36869-36872
27. Hozumi Y., Hakamata Y., and Nagai H. Plasma leptin concentration in tamoxifen-treated ovariectomized female rats. Gynecologic and Obstetric Investigation 59 (2005) 70-74
28. Hrupka B.J., Smith G.P., and Geary N. Ovariectomy and estradiol affect postingestive controls of sucrose licking. Physiology & Behavior 61 (1997) 243-247
29. Jordan V.C. Optimising endocrine approaches for the chemoprevention of breast cancer: beyond the Study of Tamoxifen and Raloxifene (STAR) Trial. European Journal of Cancer 42 (2006) 2909-2913
30. Jordan V.C. The science of selective estrogen receptor modulators: concept to clinical practice. Clinical Cancer Research: an Official Journal of the American Association for Cancer Research 12 (2006) 5010-5013
31. Jordan V.C., and Morrow M. Tamoxifen, raloxifene, and the prevention of breast cancer. Endocrine Reviews 20 (1999) 253-278
32. Kaplan J.M., Baird J.P., and Grill H.J. Dissociation of licking and volume intake controls in rats ingesting glucose and maltodextrin. Behavioral Neuroscience 115 (2001) 188-195
33. Kedar R.P., Bourne T.H., Powles T.J., Collins W.P., Ashley S.E., Cosgrove D.O., and Campbell S. Effects of tamoxifen on uterus and ovaries of postmenopausal women in a randomised breast cancer prevention trial. Lancet 343 (1994) 1318-1321
34. Kumar N.B., Allen K., Cantor A., Cox C.E., Greenberg H., Shah S., and Lyman G.H. Weight gain associated with adjuvant tamoxifen therapy in stage I and II breast cancer: fact or artifact?. Breast Cancer Research and Treatment 44 (1997) 135-143
35. Lopez M., Lelliott C.J., Tovar S., Kimber W., Gallego R., Virtue S., Blount M., Vazquez M.J., Finer N., Powles T.J., O'Rahilly S., Saha A.K., Dieguez C., and Vidal-Puig A.J. Tamoxifen-induced anorexia is associated with fatty acid synthase inhibition in the ventromedial nucleus of the hypothalamus and accumulation of malonyl-CoA. Diabetes 55 (2006) 1327-1336
36. McDonnell D.P. The molecular pharmacology of SERMs. Trends in Endocrinology and Metabolism: TEM 10 (1999) 301-311
37. Mead L., Hargreaves E., and Galea L. Sex differences in rodent spontaneous activity levels. In: Sanberg P.R., Ossenkopp K.-P., and Kavaliers M. (Eds). Motor activity and movement disorders (1996), Humana Press, Totowa, NJ 111-139
38. Meli R., Pacilio M., Raso G.M., Esposito E., Coppola A., Nasti A., Di Carlo C., Nappi C., and Di Carlo R. Estrogen and raloxifene modulate leptin and its receptor in hypothalamus and adipose tissue from ovariectomized rats. Endocrinology 145 (2004) 3115-3121
39. Miele J., Rosellini R.A., and Svare B. Estradiol benzoate can function as an unconditioned stimulus in a conditioned taste aversion paradigm. Hormones and Behavior 22 (1988) 116-130
40. O'Neal M.F., Means L.W., Poole M.C., and Hamm R.J. Estrogen affects performance of ovariectomized rats in a two-choice water-escape working memory task. Psychoneuroendocrinology 21 (1996) 51-65
41. Ossenkopp K.-P., and Mazmanian D.S. The measurement and integration of behavioral variables: aggregation and complexity as important issues. Neurobehavioral Toxicology and Teratology 7 (1985) 95-100
42. Ossenkopp K.-P., and Kavaliers M. Measuring spontaneous locomotor activity in small mammals. In: Ossenkopp K.-P., Kavaliers M., and Sanberg P.R. (Eds). Measuring Movement and Locomotion: From Invertebrates to Humans (1996), R.G. Landes Company, Austin, Texas 33-59
43. Ossenkopp K.-P., Rabi Y.J., and Eckel L.A. Oestradiol-induced taste avoidance is the result of a conditioned palatability shift. NeuroReport 7 (1996) 2777-2780
44. Rohatgi N., Blau R., and Lower E.E. Raloxifene is associated with less side effects than tamoxifen in women with early breast cancer: a questionnaire study from one physician's practice. Journal of Women's Health & Gender-Based Medicine 11 (2002) 291-301
45. Sato M., Rippy M.K., and Bryant H.U. Raloxifene, tamoxifen, nafoxidine, or estrogen effects on reproductive and nonreproductive tissues in ovariectomized rats. FASEB Journal: Official Publication of the Federation of American Societies for Experimental Biology 10 (1996) 905-912
46. Schemmel R.A., Teague R.J., and Bray G.A. Obesity in Osborne-Mendle and S 5B/P1 rats: effects of sucrose solutions, castration, and treatment with estradiol or insulin. American Journal of Physiology. Regulatory, Integrative and Comparative Physiology 243 (1982) R347-R353
47. Singh M., Meyer E.M., Millard W.J., and Simpkins J.W. Ovarian steroid deprivation results in a reversible learning impairment and compromised cholinergic function in female Sprague-Dawley rats. Brain Research 644 (1994) 305-312
48. Smith G.P. John Davis and the meanings of licking. Appetite 36 (2001) 84-92
49. Somponpun S.J. Neuroendocrine regulation of fluid and electrolyte balance by ovarian steroids: contributions from central oestrogen receptors. Journal of Neuroendocrinology 19 (2007) 809-818
50. Spector A.C., Breslin P., and Grill H.J. Taste reactivity as a dependent measure of the rapid formation of conditioned taste aversion: a tool for the neural analysis of taste-visceral associations. Behavioral Neuroscience 102 (1988) 942-952
51. Spector A.C., Klumpp P.A., and Kaplan J.M. Analytical issues in the evaluation of food deprivation and sucrose concentration effects on the microstructure of licking behavior in the rat. Behavioral Neuroscience 112 (1998) 678-694
52. Spencer J.L., Waters E.M., Romeo R.D., Wood G.E., Milner T.A., and McEwen B.S. Uncovering the mechanisms of estrogen effects on hippocampal function. Frontiers in Neuroendocrinology 29 2 (2008) 219-237
53. Tarttelin M.F., and Gorski R.A. The effects of ovarian steroids on food and water intake and body weight in the female rat. Acta Endocrinologica 72 (1973) 551-568
54. van den Brandt P.A., Spiegelman D., Yaun S.-S., Adami H.-O., Beeson L., Folsom A.R., Fraser G., Goldbohm R.A., Graham S., Kushi L., Marshall J.R., Miller A.B., Rohan T., Smith-Warner S.A., Speizer F.E., Willett W.C., Wolk A., and Hunter D.J. Pooled analysis of prospective cohort studies on height, weight, and breast cancer risk. American Journal of Epidemiology 152 (2000) 514-527
55. Vogel V.G., Costantino J.P., Wickerham D.L., Cronin W.M., Cecchini R.S., Atkins J.N., Bevers T.B., Fehrenbacher L., Pajon Jr. E.R., Wade III J.L., Robidoux A., Margolese R.G., James J., Lippman S.M., Runowicz C.D., Ganz P.A., Reis S.E., McCaskill-Stevens W., Ford L.G., Jordan V.C., and Wolmark N. Effects of tamoxifen vs raloxifene on the risk of developing invasive breast cancer and other disease outcomes: the NSABP study of tamoxifen and raloxifene (STAR) P-2 trial. JAMA: The Journal of the American Medical Association 295 (2006) 2727-2741
56. Wade G.N., and Heller H.W. Tamoxifen mimics the effects of estradiol on food intake, body weight, and body composition in rats. American Journal of Physiology. Regulatory, Integrative and Comparative Physiology 264 (1993) R1219-R1223
57. Wade G.N., and Powers J.B. Tamoxifen antagonizes the effects of estradiol on energy balance and estrous behavior in Syrian hamsters. American Journal of Physiology. Regulatory, Integrative and Comparative Physiology 265 (1993) R559-R562
58. Wakeling A.E. Tissue-specific actions of antioestrogens. Mutation Research 333 (1995) 45-49
59. Walf A.A., and Frye C.A. ERbeta-selective estrogen receptor modulators produce antianxiety behavior when administered systemically to ovariectomized rats. Neuropsychopharmacology 30 (2005) 1598-1609
60. Walf A.A., and Frye C.A. A review and update of mechanisms of estrogen in the hippocampus and amygdala for anxiety and depression behavior. Neuropsychopharmacology 31 (2006) 1097-1111
61. Walf A.A., and Frye C.A. Administration of estrogen receptor beta-specific selective estrogen receptor modulators to the hippocampus decrease anxiety and depressive behavior of ovariectomized rats. Pharmacology, Biochemistry and Behavior 86 (2007) 407-414
62. Walf A.A., Ciriza I., Garcia-Segura L.M., and Frye C.A. Antisense oligodeoxynucleotides for estrogen receptor-β and α attenuate estradiol's modulation of affective and sexual behavior, respectively. Neuropsychopharmacology 33 (2007) 431-440
63. Wallen W.J., Belanger M.P., and Wittnich C. Sex hormones and the selective estrogen receptor modulator tamoxifen modulate weekly body weights and food intakes in adolescent and adult rats. Journal of Nutrition 131 (2001) 2351-2357
64. Young J.K., Gustavson C.R., and Gustavson J.C. Estrogen-induced food aversion in the rat relevance to anorexia nervosa. Annals of the New York Academy of Sciences 575 (1989) 599-601
65. Young E.A., Altemus M., Parkison V., and Shastry S. Effects of estrogen antagonists and agonists on the ACTH response to restraint stress in female rats. Neuropsychopharmacology 25 (2001) 881-891
66. Yuan D.L., and Chambers K.C. Estradiol accelerates extinction of lithium chloride-induced conditioned taste aversions through its illness-associated properties. Hormones and Behavior 36 (1999) 287-298